Nathan Williams

Nathan Williams is an associate in Dechert’s product liability and mass torts practice and focuses on complex product liability, mass torts and environmental exposure liability.

Mr. Williams has been involved in various stages of litigation defense, from case development and pretrial proceedings to case resolution. He has experience with the affirmative and defensive aspects of fact and expert discovery, including working up and taking depositions of parties and experts. He has also briefed Daubert and dispositive motions in federal court.

Mr. Williams has defended leading companies in the pharmaceutical and performance materials industries in high-stakes litigations involving claims for personal injury, property damage and medical monitoring.

Prior to joining Dechert, Mr. Williams was an associate at Quinn Emanuel Urquhart & Sullivan.

Saint-Gobain as national and trial counsel in a high-profile environmental toxic tort litigation. Currently defending individual and class action complaints involving medical monitoring and property damages claims in New York, New Hampshire and Vermont.
Pfizer as national coordinating counsel in the Lipitor MDL, where 3,000+ plaintiffs alleged that a cholesterol-lowering medication caused them to develop Type 2 diabetes. Dechert’s Daubert strategy led to exclusion of plaintiffs’ experts on general causation grounds and the granting of summary judgment in all cases in the MDL. The Fourth Circuit unanimously affirmed. Dechert subsequently obtained a similar victory in California Superior Court after the product was spun off from Pfizer to Viatris.

Nathan Williams

Office

New York

Services

Industries

Education

Admission